NCT04997395View on ClinicalTrials.gov

Feasibility of Cannabidiol for the Treatment of Long COVID

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 14, 2022

Primary Completion Date

January 6, 2023

Study Completion Date

January 6, 2023

Conditions
Long COVID
Interventions
DRUG

MediCabilis Cannabis sativa 50

Already described

Trial Locations (1)

Unknown

Drug Science, York

Sponsors

Lead Sponsor

Bod Australia
All Listed Sponsors
collaborator

Drug Science, UK

OTHER

lead

Bod Australia

INDUSTRY

NCT04997395 - Feasibility of Cannabidiol for the Treatment of Long COVID | Biotech Hunter | Biotech Hunter